The Dermatology CRO for Biotech, Powered by Technology
Delivering faster, better, cheaper dermatology trial results for biotech sponsors
Our Dermatology CRO Executive Team
Our Dermatology CRO team has extensive experience leading CROs across indications
Our experienced CRO executive team works closely with our expert site operations team to continuously review execution strategies, closely monitor patient recruitment efforts, and mitigate key study risks for Dermatology clinical trials.
Orin Goldblum, MD
Medical Monitor
Board certified dermatologist with more than 35 years of experience in clinical practice, medical affairs, and drug development
Connect with Janet
Powered By Our Connected Technology Platform
The Vial Technology Platform leverages connected systems and intuitive design to run global trials efficiently at scale
Vial’s modern technology platform brings clinical trials out of the paper stone age, allowing for streamlined processes inside one end-to-end system.
No-Nonsense Pricing
Vial offers sponsors fixed-pricing
agreements with no change orders — ever.
Flat-rate pricing
Zero change orders
Risk-share
on commitments
Accountability
on commitments
A fixed-fee pricing model guarantees a set budget for the entirety of a project, regardless of the time and expense that accrues. Vial reserves the right to modify pricing in accordance with amendments to the study design or protocol.
Vial offers fixed upfront pricing to benefit sponsors:
- Align Incentives
- Transparent budget visibility
- No unexpected charges/fees
- Shared accountability on commitments
- Build trust and deepen the relationship
- Experienced team committed to timelines
- Next-generation technology to streamline workflows and process
- A renowned scientific advisory board providing expert insight
- Deep industry relationships and a preferred site network provide an insider view on trial pain points, allowing us to target and prepare to prevent common errors or delays
Modern Recruiting Platform
We recruit patients across multiple channels and convert them to randomizations — radically reducing enrollment periods
We use the most effective digital tools to reach, screen, and enroll motivated subjects quicker. Our optimized process can cut recruitment times in half.
EMR Integrations
HIPAA compliant automated data pulls and Inclusion/Exclusion reviews.
Fast Start-up and Consolidated Site Activation
Vial’s Site Startup App enables sites to seamlessly onboard to our trials
The results: Lightning fast onboarding for sites to be activated in as few as 30 days.
Scientific Advisory Board
Vial CRO is supported by a team of Scientific Advisors who review and provide input on the strategy and direction of the CRO in order to build the infrastructure to advance Dermatology research.
Waldman Professor and Chairman of the Kimberly and Eric J. Waldman Department of and Chairman of the Department of Dermatology at the Mount Sinai Hospital in New York City
View Profile
Senior physician of Pariser Dermatology Specialist and Principal Investigator
View Profile
Associate Professor in the Department of Dermatology and Department of Medicine, Division of Rheumatology at Harvard Medical School
View Profile
Professor and Chair of Dermatology, Residency Program Director of Translational Research, and Director of Supportive Oncodermatology at George Washington University
Vial Dedicated Phase I Unit
Vial’s Dermatology Phase 1 unit provides a unified full service solution to early clinical development.
Phase 1 Units are critical to advancing care and validating treatments, which is why it is essential to have a dependable Phase 1 unit you can rely on.

Vial’s dedicated Phase 1 research coordinators have upwards of 25 years of experience and are IATA and CPR certified. All of our research coordinators complete annual GCP and NIH training, as well as routine in-house training. In addition to extensive training, they are familiar with multiple EDS and IWRS systems, making them a well-rounded team you can trust.
500+
Dermatology Clinical Trials
10,000 +
Randomized Patients
Upcoming Events
Past Events
Webinar: Tech-Enabled Dermatology Clinical Trials — Delivering Faster, Higher Quality Trials for Sponsors
Tech-Enabled Remote Monitoring Part 1
Download the Vial CRO's white paper to learn more about each stakeholder’s benefits of tech-enabled trials.
Tech-Enabled Remote Monitoring Part 2
Download the Vial CRO's white paper to learn more about each stakeholder’s benefits of tech-enabled trials.
Vial’s Deployment of Modern, Intuitive Electronic Source
Download the Vial CRO's latest white paper to learn how utilizing eSource in clinical trials can streamline process, increase efficiency, and minimize...
Vial Announces Enrollment of First Patient in Phase II Clinical Trial TLL018-205 for the Treatment of Plaque Psoriasis Sponsored by Highlightll Pharmaceutical
Advancing Dermatology Care
Dermatological conditions can have a significant impact on patients' quality of life.
Clinical trials are critical for developing new treatments and advancing care for patients with dermatological conditions, which affect their physical appearance, causing discomfort and pain, and impacting mental health. Vial offers dermatology sponsors solutions that enable them to improve the efficiency of their clinical trials and accelerate the development of effective therapies. By improving patient outcomes and quality of life, Vial CRO's support contributes to advancing dermatology research and treatment options.
Indications
Multifaceted Clinical Trial Execution Across Dermatology Indications and Phases
- Acne Vulgaris
- Actinic Keratosis
- Alopecia Areata
- Androgenetic Alopecia
- Atopic Dermatitis
- Augmentation
- Basal Cell Carcinoma
- Breast Scars
- Bullous Pemphigoid
- Chronic Spontaneous
- Common Warts
- Dermal Fillers
- Fat Reduction
- Hand Eczema
- Hyperhidrosis
- Keloids
- Melanoma
- Molluscum Contagiosum
- Neurofibromas
- Onychomycosis
- Pachyonychia Congenita
- Prurigo Nodularis
- Pruritus
- Psoriasis
Connect with us.
Interested in receiving a proposal from Vial? Leave us a message and some of your contact info and we’ll be in touch with you shortly.
